Drugs that contain Levomilnacipran Hydrochloride
1. Drug name - FETZIMA
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US8865937 | ALLERGAN | Crystalline forms of (1S,2R)-2-(amino methyl)-N,N-diethyl-1-phenyl cyclopropane carboxamide |
May, 2032
(9 years from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| USRE43879 | ALLERGAN | Use of the dextrogyral enantiomer of milnacipran for the preparation of a drug |
Jan, 2026
(3 years from now) | |
| US8481598 | ALLERGAN | Stable dosage forms of levomilnacipran |
Mar, 2031
(8 years from now) | |
Treatment: Treatment of major depressive disorder (mdd)
Dosage: CAPSULE, EXTENDED RELEASE;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| EQ 20MG BASE | CAPSULE, EXTENDED RELEASE;ORAL | Prescription |
| EQ 40MG BASE | CAPSULE, EXTENDED RELEASE;ORAL | Prescription |
| EQ 80MG BASE | CAPSULE, EXTENDED RELEASE;ORAL | Prescription |
| EQ 120MG BASE | CAPSULE, EXTENDED RELEASE;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.